Provided herein are deuterated compounds and compositions useful in increasing PPARδ activity. The compounds have a formulawhere L5 comprises at least one deuterium. Exemplary species includeThe compounds and compositions provided herein are useful for the treatment of PPARδ related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).